Lactational Amenorrhoea Method (LAM)

The Lactational Amenorrhoea Method is a temporary, physiological, hormone-free method of postpartum contraception that exploits the natural infertility produced by intensive breastfeeding. It is a high-value counselling topic in postpartum care and a frequent, straightforward recall item in NEET PG covering its three criteria, its mechanism via prolactin, and its 98% efficacy.

Definition

LAM is the use of exclusive (or near-exclusive) breastfeeding as a contraceptive method during the first six months postpartum, in a woman who remains amenorrhoeic. It is a recognised, evidence-based natural family planning method endorsed by the WHO, FIGO, and the Bellagio Consensus (1988), which formalised the criteria.

High-yield: LAM is effective ONLY when all three criteria are simultaneously met. Failure of any one criterion means the woman is no longer protected and must start an alternative method immediately.

The method is sometimes called the "natural" or "physiological" method of postpartum contraception and forms the basis of the global recommendation to begin complementary contraceptive counselling well before six months postpartum.

The Three LAM Criteria

These three conditions are the single most tested fact of this topic. Remember them as the "3 A's of LAM" loosely, or simply the triad below.

#	Criterion	Requirement for LAM to be valid
1	Amenorrhoea	The woman must remain amenorrhoeic (no return of menses). Any vaginal bleeding after 56 days / 8 weeks postpartum is considered a return of menstruation.
2	Exclusive (or near-exclusive) breastfeeding	Baby is fed only breast milk, on demand, day and night; no regular supplementary feeds, water, or long inter-feed gaps.
3	Within 6 months postpartum	The infant is less than 6 months (24 weeks) old.

High-yield: The classic NEET PG answer for the three LAM criteria is (1) exclusive breastfeeding, (2) amenorrhoea, and (3) infant under 6 months of age. All three together → ~98% efficacy.

A useful memory aid:

Mnemonic — "BAM!"

• B — Breastfeeding exclusively (on demand, day and night)
• A — Amenorrhoea (no return of periods)
• M — Months less than six (infant age < 6 months)

What counts as "exclusive/near-exclusive" breastfeeding?

• Breastfeeding should account for ≥85% of feeds.
• Intervals between feeds should not exceed 4 hours during the day and 6 hours at night.
• Frequent suckling is the key driver — it is the suckling stimulus, not merely the presence of milk, that maintains the contraceptive effect.

High-yield: Night feeds are critical. Prolonged night-time gaps reduce nocturnal prolactin surges and can allow the return of ovulation even if other criteria appear met.

Physiology & Mechanism

The contraceptive effect rests on suckling-induced hyperprolactinaemia and consequent suppression of the hypothalamic–pituitary–ovarian (HPO) axis.

Suckling → afferent neural signals to hypothalamus → ↑ Prolactin (anterior pituitary) + disruption of pulsatile GnRH → ↓ LH pulsatility → no LH surge → anovulation → amenorrhoea.

Step-by-step pathway:

1. Suckling stimulus at the nipple sends afferent impulses to the hypothalamus.
2. This inhibits pulsatile GnRH secretion from the arcuate nucleus.
3. Reduced GnRH pulses → reduced pulsatile LH secretion from the anterior pituitary (FSH is relatively preserved).
4. Suckling simultaneously raises prolactin (via reduced dopaminergic/PIF tone and reflex prolactin release).
5. High prolactin further suppresses GnRH and acts directly on the ovary to blunt follicular responsiveness to gonadotropins.
6. Net result → absent mid-cycle LH surge → anovulation → lactational amenorrhoea.

High-yield: The central hormone is prolactin; the central defect is loss of the LH surge due to suppressed pulsatile GnRH. Oestrogen levels are low, contributing to lactational vaginal dryness.

Hormone	Status during effective lactation	Consequence
Prolactin	Markedly elevated (highest with frequent suckling)	Suppresses GnRH; supports milk synthesis
GnRH (pulsatile)	Suppressed	Loss of downstream LH pulsatility
LH	Low / no surge	Anovulation
FSH	Returns relatively early / near-normal	Some follicular activity may resume but no ovulation
Oestrogen	Low	Amenorrhoea, vaginal dryness, low bone-turnover concern
Oxytocin	Pulsatile with let-down	Milk ejection (not contraceptive)

Note that oxytocin mediates the milk-ejection (let-down) reflex and is not the contraceptive hormone — a common distractor. Prolactin is responsible for both milk synthesis and ovulation suppression.

Efficacy

Use	Failure rate (first 6 months)	Effectiveness
Perfect use (all 3 criteria strictly met)	~0.5–1%	~99%
Typical use	~2%	~98%

High-yield: Quote LAM efficacy as 98% (typical use) in the first 6 months — this is the standard NEET PG figure. Perfect use approaches 99%.

The efficacy is time-limited: protection falls off sharply once any criterion lapses, and after 6 months the cumulative pregnancy risk rises even with continued breastfeeding because ovulation frequently precedes the first menses.

Return of Fertility & Transition

A crucial counselling point — ovulation can return before the first menstrual period. The first postpartum cycle may be ovulatory, so a woman relying on amenorrhoea alone can conceive "before her first period."

When to switch / start a backup method (any of the following):

1. The infant reaches 6 months of age, OR
2. Menstruation returns (any bleeding after 8 weeks postpartum), OR
3. Breastfeeding becomes non-exclusive (supplementary feeds, weaning, long feed gaps).

When ANY one of these occurs → start an alternative contraceptive immediately.

Choice of follow-on contraception in breastfeeding women

Method	Suitability during lactation	Notes
Progestin-only pills (POP)	Preferred	No effect on milk volume; WHO MEC Category 1 after ~6 weeks
DMPA / injectable progestin	Suitable	Long-acting; can start ~6 weeks postpartum
Cu-IUCD / LNG-IUS	Excellent	Can be inserted within 48 h postpartum or after 4 weeks; LAM-independent
Implants (etonogestrel/LNG)	Suitable	Highly effective, progestin-only
Barrier methods (condom)	Suitable	Simple bridging option
Combined OCPs (oestrogen-containing)	Avoided until milk established	Oestrogen reduces milk supply; WHO MEC Category 4 (<6 wk), Category 3 (6 wk–6 mo)

High-yield: Progestin-only methods (POP, DMPA, implant, LNG-IUS) are the contraceptives of choice during lactation. Combined oestrogen-containing pills are avoided in the early postpartum/breastfeeding period because oestrogen suppresses lactation and adds thrombotic risk.

Advantages & Disadvantages

Advantages

• No cost, no drugs, no devices, immediately available postpartum.
• No effect on milk supply (it depends on milk supply).
• Promotes exclusive breastfeeding — benefits infant nutrition, immunity, and mother–infant bonding.
• No systemic side effects; suitable for the woman who wishes to avoid hormones.
• Encourages early contraceptive counselling.

Disadvantages / limitations

• Short duration of protection (only up to 6 months and only while strictly amenorrhoeic + exclusively breastfeeding).
• Efficacy is user-dependent and falls rapidly if feeding pattern changes (e.g., mother returns to work, infant sleeps through the night).
• No protection against sexually transmitted infections (STIs/HIV).
• Lactational amenorrhoea causes hypo-oestrogenism → vaginal dryness, dyspareunia.
• Not applicable to women who cannot or choose not to breastfeed exclusively.
• HIV-positive mothers: breastfeeding decisions follow separate national PPTCT guidance.

Differentials / Distinguishing Concepts

Although LAM is a contraceptive method rather than a disease, NEET PG often tests it against related concepts:

Concept	Distinction from LAM
Physiological postpartum amenorrhoea	Amenorrhoea is the observed sign; LAM is the deliberate contraceptive use of that state with strict criteria.
Standard Days / Calendar method	Fertility-awareness based on cycle prediction; not applicable while amenorrhoeic.
Sheehan syndrome	Pathological postpartum hypopituitarism (failure of lactation + amenorrhoea + other deficiencies) — here lactation FAILS, the opposite of LAM.
Hyperprolactinaemia (prolactinoma)	Pathological amenorrhoea–galactorrhoea unrelated to suckling; very high prolactin with mass effect.
Asherman syndrome	Amenorrhoea due to intrauterine synechiae, often post-curettage — structural, not hormonal.

High-yield: Distinguish LAM (physiological, suckling-driven, desirable) from Sheehan syndrome (pathological hypopituitarism with failure of lactation) — a favourite trap pairing.

Special Situations & Counselling Pearls

• Working mothers / expressed milk: If the mother expresses milk and the baby is bottle-fed without frequent direct suckling, the prolactin surge is blunted and LAM reliability falls. Direct, frequent suckling is what matters.
• Bleeding before 8 weeks (e.g., lochial bleeding, scant spotting) is not counted as return of menstruation; bleeding after 56 days/8 weeks IS.
• Mixed/partial breastfeeding voids the "exclusive" criterion even within 6 months.
• LAM should always be counselled alongside a follow-on plan, ideally chosen antenatally or before discharge, so transition is seamless.
• Postpartum IUCD insertion (within 48 h or after 4 weeks) and postpartum sterilisation are LAM-independent and are good options if the couple desire something more definite.

Recently asked / exam angle

• "All three conditions of LAM" — pick the option with exclusive breastfeeding + amenorrhoea + infant < 6 months. Distractors usually swap "6 months" for "12 months" or drop the amenorrhoea criterion.
• Efficacy of LAM = 98% (typical use, first 6 months) — direct one-liner MCQ.
• Hormone responsible for the contraceptive effect = prolactin; mechanism = suppression of pulsatile GnRH → no LH surge → anovulation. Oxytocin is the distractor (milk let-down only).
• Contraceptive of choice in a lactating mother = progestin-only method; combined OCP is the wrong answer because oestrogen decreases milk supply.
• Scenario stems: "A woman exclusively breastfeeding, 5 months postpartum, no periods — counsel regarding contraception" → LAM is currently valid; advise switching at 6 months / return of menses / change in feeding.
• "Ovulation can occur before the first menstrual period" — true statement frequently tested as the reason LAM must be supplemented promptly.
• Pairing with WHO Medical Eligibility Criteria: combined hormonal contraceptives are MEC Category 4 if < 6 weeks postpartum in breastfeeding women.

Rapid revision

1. LAM = three criteria together → exclusive breastfeeding + amenorrhoea + infant < 6 months; failure of any one ends protection.
2. Efficacy ≈ 98% (typical use); approaches 99% with perfect use during the first 6 months.
3. Prolactin is the central hormone; it suppresses pulsatile GnRH → no LH surge → anovulation.
4. Oxytocin causes milk let-down, NOT the contraceptive effect — common distractor.
5. Suckling stimulus (frequent, including night feeds) is the driver — not just milk presence; gaps should be <4 h day, <6 h night.
6. Bleeding after 8 weeks (56 days) postpartum counts as return of menses and ends LAM.
7. Ovulation can precede the first period, so begin a backup method promptly.
8. Switch when 6 months reached OR menses return OR breastfeeding becomes non-exclusive.
9. Progestin-only methods (POP, DMPA, implant, LNG-IUS) are preferred in lactation; combined OCPs avoided (oestrogen ↓ milk supply).
10. LAM offers no STI/HIV protection and causes hypo-oestrogenic vaginal dryness.
11. Formalised by the Bellagio Consensus (1988); endorsed by WHO/FIGO.
12. Do not confuse LAM with Sheehan syndrome (pathological postpartum hypopituitarism with FAILED lactation).